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SUMMARY – Strictures are one of the most common complications of Crohn’s disease. If 
symptomatic and resistant to medical anti-inflammatory therapy, and especially in cases of acute 
obstruction, surgical correction may be unavoidable. Although surgical treatment is dramatically 
effective in curing Crohn’s disease strictures, a high rate of postsurgical restenosis has been reco-
gnized, ultimately requiring additional surgery. To avoid the risks and costs entailed by repeated 
surgical resection, endoscopic balloon dilatation (EBD) has been proposed as a conservative tre-
atment option for intestinal strictures in Crohn’s disease, in which the stricture is pneumatically 
dilated with through-the-scope balloons of different diameters. The main clinical indication for 
EBD is the appearance of obstructive symptoms associated with the stricture, especially if they are 
postoperative and shorter than 4 centimeters. Usually more than one dilatation session is required 
for every stricture. EBD is applied infrequently, possibly due to the perceived risk of perforation and 
early stricture recurrence, but studies have demonstrated that EBD has a high success rate, a low 
chance of complications, excellent symptomatic response, as well as good short-term and long-term 
outcomes, proving that it is a relatively simple and successful technique that provides long-term 
effective palliation of the symptoms with minimal risk in patients with simple strictures, and offers 
a reasonable alternative to surgery.
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Introduction
Crohn’s disease (CD) is a chronic inflammatory 
bowel disease of unknown etiology and unpredictable 
course that can affect any part of the gastrointestinal 
tract, but most commonly affects terminal ileum. The 
peak age at onset is between 15 and 30 years, more 
frequent in women, while the second peak occurs be-
tween the ages of 60 and 80. 
Crohn’s disease is characterized by an aberrant and 
persistent inflammatory process causing transmural 
lesions of the bowel wall, and by the excessive fibro-
genic response resulting in transmural fibrosis, which 
often leads to the development of complications, both 
intestinal and extra-intestinal. 
Vienna and Montreal classification of CD, as a 
clinical classification, considers age at onset (A), dis-
ease location (L), and disease behavior (B) as the pre-
dominant phenotypic elements1. By disease behavior 
(B), CD is divided into non-stricturing, non-pene-
trating (B1), stricturing (B2), and penetrating disease 
(B3), which is important in clinical practice for treat-
ment planning. 
The first line of treatment is medication, but when 
the disease does not respond or when complications 
arise and there is a need to relieve symptoms, surgery 
is required. Surgery is palliative because CD is a sur-
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gically incurable disease and implies major risks and 
complications. Most of these major complications re-
quire repeated surgical procedures.
Strictures, as the main feature of B2-stricturing 
disease and as one of the most common complications 
of CD, often require surgical resection needed to treat 
the associated subocclusive symptoms, and frequently 
recur after resection, which can lead to repeated sur-
gery. Considering the risks and costs entailed by sur-
gical resection and postoperative complications, en-
doscopic balloon dilatation (EBD) as an alternative to 
surgery and a method that pneumatically dilates CD 
strictures and thus preserves the length and function 
of the bowel, is of high clinical importance2.
Case Report
A 19-year-old woman was diagnosed with CD in 
2001, at the age of eight, after several months with 
symptoms of elevated temperature, inappetence, aph-
thous changes inside the mouth and anemia. The pa-
tient was introduced into remission with steroids and 
was without symptoms until 2006, when there was a 
recurrence that was treated with enteral nutrition. The 
next relapse occurred in 2008 and was treated with 
prednisone, following azathioprine. Azathioprine was 
discontinued due to nausea and vomiting. After six 
months, colonoscopy revealed severe ulcerations in 
the terminal ileum and aphthae in the entire colon, 
so methotrexate was introduced in therapy. In 2009, 
after another relapse, resection of the terminal ileum, 
the cecum and the ascending colon with ileotransverse 
terminolateral anastomosis was made. 
In March 2011, the patient experienced sudden 
pain in the lower right half of the abdomen and vom-
iting. She was admitted at another hospital, where 
endoscopic examination revealed stenosis of the ile-
otransverse anastomosis, and she was transferred to 
our hospital for dilatation of the stenosis. 
At the beginning of April 2011, under general 
anesthesia (propofol and fentanyl), EBD of the anas-
tomotic opening was made with through-the-scope 
(TTS) balloons of 6, 9, 12 and 15 mm in diameter 
(Fig. 1 a, b). The procedure and post-procedural 
course passed without complications and the patient 
was released from the hospital. 
At the end of April, the patient was readmitted 
to the hospital and another balloon dilatation was 
a)
b)
Fig. 1. (a) Stenosis of the ileotransverse anastomotic opening; (b) endoscopic balloon dilatation of the anasto-
motic opening with through-the-scope (TTS) balloon.
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performed with a TTS balloon of 18 mm in diam-
eter. The procedure and post-procedural course passed 
without complications (Fig. 2). Additionally, a small 
bowel follow-through (SBFT) was performed, which 
showed an isolated loop of the small intestine (which 
corresponded to jejunoileal transition), with mark-
edly irregular mucosal surface in the length of 11 cm; 
in some places shallow pseudo-ulcerations; spindle-
shaped outgrowths of the contrast medium on one 
of the projections, which corresponded to a 10 mm-
length of pseudo-diverticulum. The SBFT through 
the anastomosis was undisturbed. In therapy, meth-
otrexate was replaced with azathioprine and budes-
onide. Considering the course of the disease, the pa-
tient was scheduled for biological therapies.
After four months, magnetic resonance imag-
ing enteroclysis revealed the lumen of anastomosis of 
about 0.7 cm in diameter, with no pathologic opaci-
fication of the intestinal wall. The appearance of the 
surrounding adipose tissue showed no abnormalities.
Currently, the patient is symptom-free, and the re-
sults of clinical and laboratory tests are normal. 
Fig. 2. Result of endoscopic balloon dilatation of the 
anastomotic opening.
Discussion
Strictures, as one of the most common complica-
tions of CD, occur as a result of the healing response 
to chronic inflammation in the intestinal wall, and of 
an excessive fibrogenic response caused mainly by fi-
broblasts and smooth muscle cell activation, resulting 
in transmural fibrosis and consequently narrowing of 
the intestinal lumen. They can occur anywhere in the 
gastrointestinal tract, but most commonly affect ileo-
colonic anastomoses, terminal ileum and colon2,3.
If symptomatic and resistant to medical anti-in-
flammatory therapy, and especially in cases of acute 
obstruction or perforation, surgical correction by in-
testinal resection or stricturoplasty may be unavoid-
able3,4. It is estimated that up to 80% of CD patients 
will eventually require at least one surgical resection 
within 10 years of the diagnosis2. Postoperative com-
plications that can occur include fistulas, leaks, short 
bowel syndrome, and strictures that frequently recur 
at the anastomosis site (due to bacterial stasis from 
postoperative narrowing of the lumen, high intralu-
minal pressure and vascular compromise), thus creat-
ing a vicious cycle4.
Although surgical treatment is dramatically ef-
fective in curing CD strictures, a high rate of post-
surgical restenosis has been recognized within a 
1-year postintervention period, ultimately requiring 
additional surgery in at least 34% of cases2. Postop-
erative morbidity associated with bowel resection is 
estimated to range from 6% to 45%, and mortality 
ranges from 0.5% to 5.5%4. To avoid the risks and 
costs entailed by repeated surgical resection, EBD 
has been proposed2.
Endoscopic balloon dilatation is a non-surgical 
treatment option for intestinal strictures in Crohn’s 
disease, in which the stricture is pneumatically di-
lated with TTS balloons of different diameters. Two 
different approaches can be used: applying maximum 
caliber dilatation from the outset or starting with a 
lower caliber and gradually increasing to greater bal-
loon diameters, which we consider is safer due to a 
lower risk of perforation2. 
The use of local steroid infiltration at the site of 
dilatation is controversial, requiring further studies, 
as well as the use of antibiotics during and after the 
procedure2,3. Considering that improved prognosis 
can be achieved by good control of the disease, we did 
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not use any of the above, awaiting their application to 
be evaluated in a controlled manner.
The main clinical indication for EBD is the ap-
pearance of obstructive symptoms associated with 
the stricture, especially if they are postoperative and 
shorter than 4 centimeters because they are technically 
easier to dilate and have a lower risk of perforation, as 
opposed to de novo strictures. Usually more than one 
dilatation session is required for every stricture.
For decompression of malignant bowel obstruc-
tion, metallic enteral endoprostheses (as an upgrade to 
EBD) prowed useful in case studies, but to completely 
evaluate the success, the results of randomized studies 
are needed5.
The only predictor of a surgery-free follow-up is a 
short stricture. It remains unclear whether the failure 
of longer stricture dilatation is the result of an intrin-
sic resistance to pneumatic dilatation or a mere tech-
nical limitation2.
Endoscopic balloon dilatation is applied infre-
quently, possibly due to the perceived risk of perfora-
tion and early stricture recurrence. In the past, studies 
showed a variation in success and in complication rates, 
which was associated with variations in the techniques 
used, selection of strictures for dilatation and the in-
definable technical abilities of endoscopists. However, 
the latest studies have provided evidence that EBD 
has a high success rate, a low chance of complications, 
an excellent symptomatic response, as well as good 
short-term and long-term outcomes, proving that it 
is a relatively simple and successful technique, with 
good and prolonged symptomatic relief (Table 1)2,3.
It is important to mention that bowel perforation 
was the most common complication, but no death 
plausibly related to pneumatic dilatation has ever 
been reported, whilst there is no doubt that even the 
most conservative surgical approach is hampered by 
a definite mortality rate. In two series, a complica-
tion rate was unexpectedly high, 11% in Couckuyt’s 
series, which was widely related to its aggressive tech-
nique (up to 1-h dilatation under general anesthesia) 
and 18% in Singh’s series, which is quite enigmatic, 
considering the prudent technique adopted by the au-
thors2.
Other publications confirm these data, demon-
strating even a long-term success rate of endoscopic 
dilatation of 80%, which is remarkable. The relapse 
rate after single EBD is probably somewhat higher 
than after surgery, but by repeated dilatation of re-
lapsing strictures, surgery can be often avoided or 
























Dear6 22 91 18 No 45 100 73 0
Sabate7 38 65 25 No 56 84 53 3
Williams8 7 71 20 No 100 71 71 0
Ferlitsch9 46 62 20 Yes - 85 57 4
Brooker10 14 79 20 Yes 86 100 79 0
Gibson11 59 73 18 No 74 73 41 3
Ramboer12 13 71 18 Yes 77 100 100 0
Couckuyt13 55 67 20 No 73 85 60 11
Morini14 43 67 18 No 70 79 42 0
Blomberg15 27 100 25 No 100 100 67 0
Singh16 17 30 20 Yes 96 100 76 18
Stienecker17 25 52 18 No 97 97 94 3
Ajlouni3 37 38 18 No 84 84 75 3
Hirai18 25 0 18 No 72 72 - 8
Overall 428 63 25 - 79 88 68 3.75
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delayed17. It is reasonable to assume that the longer 
the duration of follow-up, the higher the likelihood 
of recurrence and surgery3. Furthermore, the results 
indicate that EBD adds at least 50% to the efficacy of 
a previous surgery, so it would be a serious mistake to 
consider surgery and endoscopic dilatation as antago-
nist solutions for CD patients2.
In conclusion, endoscopic dilatation of strictures 
in CD patients may achieve clinical benefit in many 
patients and provide long-term effective palliation of 
symptoms with minimal risk in patients with simple 
strictures, and offer a reasonable alternative to surgery. 
Dilatation may be repeated in recurrent intestinal ob-
structions and appears safe without morbidity4,19.
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Sažetak
ENDOSKOPSKA BALONSKA DILATACIJA POSLIJEOPERACIJSKIH CRIJEVNIH STRIKTURA KOD 
CROHNOVE BOLESTI: PRIKAZ SLUčAJA I PREGLED LITERATURE
N. Ljubičić, A. Bišćanin, I. Nikić, I. Budimir, M. Nikolić i T. Pavić
Strikture su jedna od najčešćih komplikacija Crohnove bolesti. Ako su simptomatske i rezistentne na protuupalnu tera-
piju, a naročito u slučajevima akutne opstrukcije, kirurška korekcija može biti neizbježna. Iako je kirurško liječenje izrazito 
uspješno u liječenju striktura Crohnove bolesti, endoskopski je prepoznata visoka stopa poslijeoperacijskih restenoza, što u 
konačnici zahtijeva dodatnu operaciju. Da bi se izbjegli rizici i troškovi povezani s kirurškom resekcijom predložena je en-
doskopska balonska dilatacija (EBD) kao konzervativna opcija za liječenje crijevnih striktura u Crohnovoj bolesti, kojom 
se striktura pneumatski širi TTS balonima različitih promjera. Glavna klinička indikacija za EBD je pojava opstruktivnih 
simptoma povezanih sa strikturom, osobito ako su poslijeoperacijske i kraće od 4 centimetra. Za svaku strikturu potrebno 
je u pravilu više od jedne dilatacije. EBD se ne primjenjuje često, vjerojatno zbog zapaženog rizika od perforacije i ranog re-
cidiva strikture; no, studije su pokazale da EBD ima visoku stopu uspjeha, nisku vjerojatnost komplikacija, odličan simp-
tomatski odgovor, kao i dobar kratkoročni i dugoročni ishod, dokazujući da je to relativno jednostavna i uspješna tehnika 
koja osigurava dugotrajno i učinkovito ublažavanje simptoma uz minimalan rizik u bolesnika s jednostavnim strikturama, 
te da nudi razumnu alternativu operaciji.
Ključne riječi: Striktura, patološka – kirurgija; Endoskopija, gastrointestinalna – metode; Crohnova bolest – komplikacije
